FDA — authorised 2 August 2006
- Application: NDA021881
- Marketing authorisation holder: SALIX PHARMS
- Local brand name: MOVIPREP
- Indication: FOR SOLUTION — ORAL
- Status: approved
🇺🇸 Polyethyleneglycol in United States
FDA authorised Polyethyleneglycol on 2 August 2006
Marketing authorisations
FDA
- Status: approved
Polyethyleneglycol in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Polyethyleneglycol approved in United States?
Yes. FDA authorised it on 2 August 2006; FDA has authorised it.
Who is the marketing authorisation holder for Polyethyleneglycol in United States?
SALIX PHARMS holds the US marketing authorisation.